Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells
Open Access
- 15 June 2025
- journal article
- research article
- Published by Springer Nature in Biomarker Research
- Vol. 13 (1) , 1-15
Abstract
Background: The combination of epirubicin, cisplatin, and 5-fluorouracil (ECF) is widely used for gastric cancer treatment. However, cancer cells can acquire chemoresistance over multiple treatment cycles, leading to recurrence. This study aimed to investigate a novel biomarker for predicting ECF resistance and its biological roles in gastric cancer. Methods: ECF-resistant (ECF-R) gastric cancer cell lines were established through stepwise ECF treatment. Transcriptome analysis was performed to identify resistance-related genes, which were validated in tumor organoids and in vivo models. Additionally, gastric cancer patient tumor tissues were analyzed for clinical relevance. Results: Transcriptome analysis revealed that NINJURIN2 and CD44 were highly expressed in ECF-R cells but rarely expressed in normal gastric tissues. NINJURIN2 inhibition significantly increased chemosensitivity to ECF in vitro and in vivo. Liquid chromatography–tandem mass spectrometry identified periostin as a binding partner of NINJURIN2, mediating chemoresistance. Furthermore, VAV2 phosphorylation was markedly upregulated in ECF-R cells but was inhibited by NINJURIN2 knockdown. Clinical analysis showed that high NINJURIN2 expression correlated with poor survival outcomes in gastric cancer patients. Conclusion: Our findings suggest that NINJURIN2 can be used as a novel biomarker for chemoresistant gastric cancer patients and that inhibiting NINJURIN2 along with standard chemotherapy could prevent chemoresistance-associated relapse in gastric cancer.Keywords
Funding Information
- National Research Foundation of Korea (2022R1A2C1008868, 2022R1A2C1013380)
This publication has 50 references indexed in Scilit:
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- The P2Y2 Nucleotide Receptor Interacts with αv Integrins to Activate Go and Induce Cell MigrationJournal of Biological Chemistry, 2005
- Vav GEFs are required for β2 integrin-dependent functions of neutrophilsJournal of Cell Biology, 2004
- Gene Ontology: tool for the unification of biologyNature Genetics, 2000
- Ninjurin2, a Novel Homophilic Adhesion Molecule, Is Expressed in Mature Sensory and Enteric Neurons and Promotes Neurite OutgrowthThe Journal of Neuroscience, 2000
- Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialBritish Journal of Cancer, 1999
- A Third-Generation Lentivirus Vector with a Conditional Packaging SystemJournal of Virology, 1998
- Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell linesBritish Journal of Cancer, 1991
- Determination of subcutaneous tumor size in athymic (nude) miceCancer Chemotherapy and Pharmacology, 1989
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMAActa Pathologica Microbiologica Scandinavica, 1965